The most groundbreaking potential application of BTKis is for rapid-onset prevention of IgE-mediated anaphylaxis, which is a potentially life-threatening systemic allergic reaction to foods, drugs, stinging insect venoms, or other substances. The gene discussed is IGHE; the disease is allergic disease.